Literature DB >> 17401709

Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital.

A M v d Hoeven1, M Scholing, P C Wever, R Fijnheer, M Hermans, P M Schneeberger.   

Abstract

OBJECTIVES: Rapid diagnosis of influenza in hospitalised patients is important to prevent the transmission of the infection in the hospital. This prospective observational cohort study was designed to determine the relationship between the clinical diagnosis of influenza made by the physician at admission and the presence of influenza virus in patients with respiratory tract infections.
METHODS: This prospective observational cohort study was conducted in a large Dutch teaching hospital in a period of four weeks during the influenza season 2004/2005. All patients of 18 years and older, admitted with respiratory tract infections were included in the study. Clinical and laboratory parameters, chest radiograph (CR), blood and sputum cultures and nasopharyngeal swab for polymerase chain reaction (PCR) were obtained for each patient. In addition, the physicians opinion at admission whether this patient had influenza was recorded.
RESULTS: A total of 78 patients were hospitalized with respiratory tract infections. In 41 (53%) of them influenza virus was detected by PCR. Among the patients that were positive for influenza virus by PCR, a clinical diagnosis of influenza was made in 18 cases (44%). Conversely, clinical diagnosis of influenza was made in 16 out of 37 patients in whom influenza virus was not detected by PCR. Neither C-reactive protein, leucocytes count nor an infiltrate on CR were helpful in determining the cause of the respiratory tract infection.
CONCLUSIONS: The present findings failed to demonstrate a significant relationship between the clinical diagnosis of influenza and PCR detection of the virus. Also, the virus was present at least twice more often than influenza was clinically diagnosed. As a consequence, the decision to take protective measures to control spread of the virus should not rely on the clinical diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17401709      PMCID: PMC2778620          DOI: 10.1007/s15010-007-6112-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


Introduction

In winter 2004/2005 the most extensive influenza epidemic of the past five years occurred in the Netherlands. The usual background of 3 per 10,000 cases of an influenza-like illness was exceeded largely, namely 104 per 10,000 inhabitants. [1] Based on recordings of the Dutch Institute for Healthcare Research (NIVEL) this influenza epidemic caused more serious illness than in previous years and a corresponding level of high mortality. In the southern regions of the country, influenza activity was the highest and accompanied by a two-fold increase in all-cause mortality. Influenza is characterized by systemic symptoms like fever, cough, artralgia, headache, chills, malaise, fatigue and myalgia. However, there are various diseases with similar clinical features. This makes the clinical diagnosis of influenza in patients presenting at the Emergency Room (ER) difficult. [2, 3] The combination of fever and cough may be indicative for the clinical diagnosis of influenza during a seasonal epidemic. [4-7] In general practice at the ER however, differentiating viral from bacterial infections is difficult. Nevertheless rapid diagnosis of influenza is important for prevention of transmission of the virus and treatment with antiviral drugs. Laboratory diagnosis of influenza with pharyngeal culture of the virus is considered the ‘gold standard’. However, results from cell culture take 2 to 14 days, and rapid diagnostic kits for influenza lack sensitivity. Polymerase chain reaction (PCR) is a sensitive and specific test for influenza, with test results obtainable within 24–48 hours. [8] This prospective study was designed to determine the relationship between the clinical diagnosis of influenza made by the physician at admission and the presence of influenza virus in patients with respiratory tract infections. The results of this study may be of importance for the management of influenza pandemic.

Material and Methods

This prospective observational cohort study was conducted during the influenza season 2004/2005 over a period of four weeks (week 8 until week 11) in a large Dutch teaching hospital in the southern regions of the country, where influenza activity was the highest. The hospital serves a semi-rural region with one major city of 100,000 inhabitants (1250 km2) with an overall population of 350,000 inhabitants. All patients of 18 years and older, presenting at the ER with respiratory tract infection, were questioned and examined to assess clinically whether this was a case of influenza or not. Prospective definitions of respiratory tract infection and of influenza-like illness were made available to the physician, according to definitions used in literature. [2, 15] Influenza-like illness was defined as fever (defined as a temperature >38 degrees) with at least two of the following: cough, sore throat, myalgia and headache. [2] Only patients admitted to the hospital were included in the study. The physician at the ER recorded the findings of the medical history and physical examination as well as the severity of the illness and risk of mortality with the Pneumonia Severity Index (PSI). [9] This score consists of patient parameters like age, underlying disease, physical and laboratory parameters. For each patient routine investigation was done: Laboratory investigation (full blood count, renal and liver function, C-reactive protein (CRP) and arterial blood gas), chest radiograph (CR), blood and sputum cultures, as well as a pharyngeal swab for PCR influenza. Not routinely serology for Mycoplasma, Chlamydia and Legionella was performed, however only in cases with clinical suspicion for infection with an atypical organism. On admission, the physician was asked to clinically diagnose each patient either as an influenza case or a non influenza case. As soon as the test results of PCR influenza virus were available, the physician in charge of the ward was contacted in order to take protective measures and adjust treatment. Test results of the PCR were available within 48 hours. Pharyngeal swabs for he detection of influenza virus were simultaneously tested by (1) a real-time PCR directed at highly conserved regions coding for the matrix protein of influenza viruses A and B and (2) multiplex real-time PCR directed at highly conserved regions coding for the matrix protein of influenza virus A and the hemaglutinin gene segment of influenza virus B, including routine internal controls. [10, 11] Other materials like blood and sputum cultures were processed in the daily routine of the microbiological laboratory. Data were processed with SPSS. Differences between patients with PCR influenza virus positive and negative were analysed with analysis of variance (ANOVA). Cross tabs were used for testing the correlation between discrete variables, ANOVA for testing the correlation between the mean values of a continuous variable in the two different groups of patients. P values <0.05 were considered significant.

Results

A total of 78 patients were included in the study period (Figure 1). In 41 (53%) out of 78 patients influenza virus was detected by PCR. There were no discrepant results between both PCR tests. 29 out of 41 patients tested positive for influenza A, 10 for influenza B and 2 for influenza A and B. The clinical diagnosis of influenza was made in 18 out of 41 cases in which influenza virus was detected by PCR. Conversely, clinical diagnosis of influenza was made in 16 out of 37 patients in whom influenza virus was not detected by PCR. Sensitivity and specificity of the clinical diagnosis were 60% and 53% respectively. Table 1 shows patient characteristics of the study cohort. Neither the value of CRP, leukocyte count nor the presence of an infiltrate on CR could discriminate wether this was a case of influenza or not. Mean body temperature at admission was similar in both groups and cough was present in 75% of all patients in both groups. More patients with chronic obstructive pulmonary disease (COPD) tested positive for influenza virus.
Figure 1

Epidemiology of the 2005 Dutch influenza epidemic related to the patients included into the study.

Table 1

Patient characteristics.

Patient characteristicsPCR influenza virus negative (N = 37)PCR influenza virus positive (N = 41)Statistical signifi canee
Age (years)*65 ± 17 range 22–8872 ± 16 range 32–94Ns
Female/Male14/2318/23Ns
Suspicion of influenza1618Ns
Suspicion bacterial infection1412Ns
Not scoreda/nr711Ns
Leucocytes (109/nr/l)*11.0 ± 4,9 range 1–2511.0 ± 10,6 range 1–70Ns
CRP(mg/l)*116 ± 127 range 6–52796 ± 96 range 6–324Ns
Infiltrate on CR1310Ns
Temperatura*37,7 ± 1,3 range 34,5–40,237,8 ± 0,8 range 36,3–39,3Ns
Comorbidityb2420Ns
COPD824p < 0,001
Treatment with antibiotics3438Ns
Length of hospital stay (days)*12 ± 11 range 2–4010 ± 7 range 1–40Ns
Number of patients died44Ns

* Mean value; a Not scored means the physician could not make a clear statement based upon clinical signs whether this patient had influenza or not; b comorbidity e.g. diabetes mellitus, cardiovascularb disease, renal insufficiency; ± standard deviation from the mean; Ns: Non significant

Patient characteristics. * Mean value; a Not scored means the physician could not make a clear statement based upon clinical signs whether this patient had influenza or not; b comorbidity e.g. diabetes mellitus, cardiovascularb disease, renal insufficiency; ± standard deviation from the mean; Ns: Non significant Epidemiology of the 2005 Dutch influenza epidemic related to the patients included into the study. Table 2 shows results of bacteriological testing and serology. PSI score III or higher was significantly correlated with longer hospital stay, both for patients with PCR influenza virus negative (p = 0.001) and for patients with PCR influenza virus positive (p = 0.018) (Table 3). Patients testing positive for PCR influenza virus had significantly higher PSI (score >III) (p = 0.014). PSI was significantly correlated with mortality. A total of 8 patients died, 4 in each group (Table 3). Patients with co morbidity like diabetes, cardiovascular disease and renal insufficiency had significantly longer duration of hospital stay (p = 0.03).
Table 2

Results bacteriological testing.

Micro-organismPCR negativePCR positive
Total3741
No diagnosis24
Only influenza virus32
H. influenzae65
S. pneumoniae32
Mycoplasma21
Other21
Table 3

Correlation between hospital stay and Pneumoniae Severity Index (P.S.I.) for patients with PCR influenza virus negative and positive, showing a significantly longer duration of hospital stay for patients with PSI risk class 3 or more (p = 0.001 and p = 0.018). The last two columns show that patients testing positive for PCR influenza had significantly higher PSI (p = 0.014) than patients testing negative.

Pneumoniae Severity Index risk classMean duration of hospital stay (days) for PCR influenza negative patientsMean duration of hospital stay (days) for PCR influenza positive patientsNumber of patients with PCR influenza negativeNumber of patients with influenza PCR positive
16 ± 4 (range 2–14)6 ± 5 (range 1–13)105
28 ± 2 (range 4–9)6 ± 3 (range 2–9)95
39 ± 5 (range 4–15)10 ± 3 (range 5–15)514
417 ± 11 (range 8–40)14 ± 10 (range 5–40)9[3]a15 [4]
532 ± 7 (range 26–40)14 ± 3 (range 11–16)4 [1]2

a indicates the number of patients that died

Results bacteriological testing. Correlation between hospital stay and Pneumoniae Severity Index (P.S.I.) for patients with PCR influenza virus negative and positive, showing a significantly longer duration of hospital stay for patients with PSI risk class 3 or more (p = 0.001 and p = 0.018). The last two columns show that patients testing positive for PCR influenza had significantly higher PSI (p = 0.014) than patients testing negative. a indicates the number of patients that died None of the patients included in the study had been isolated or treated with antiviral drugs.

Discussion

The results of this prospective cohort study show that 41 out of 78 (53%) patients admitted with respiratory tract infection were PCR influenza virus positive. The high number of patients tested positive with PCR influenza virus can be explained by the fact that this influenza epidemic was more severe than in previous years and that its activity was highest in the southern regions of the country, where the study was conducted. PCR is a reliable method for detection of the presence of influenza virus. However the presence of the influenza virus may not always be the cause of the illness leading to the hospital admission. We found no significant relationship between the clinical diagnosis of influenza and PCR detection of the virus. In our study clinical signs such as cough and fever were not helpful in discriminating the cause of respiratory infections in patients admitted to the hospital. Similar results have been observed in another study that shows only half of hospitalized patients with influenza actually meet the Center for Disease Control and Prevention (CDC) criteria for influenza. [15] These results are in contrast to other studies that show that a combination of clinical signs such as fever and cough have greater predictive value for influenza. [4–7, 13, 14] However, some of these studies were done retrospectively and most of them included mainly outpatients. [4-7] Performance of clinical diagnosis has also been assessed prospectively in a study on neuraminidase inhibitors. This study establishes a poor predictive value of the clinical case definition, precluding its use for decision-making in hospitals during influenza epidemics. [8] Patients presenting at our ER are usually treated by their family physician before they are referred to the ER. Also, most patients have co-morbidity, like COPD, making a clinical sign like cough not helpful in discriminating the cause of the infection. Moreover, the hospital where the study is performed is a large training hospital, where the interns may be less experienced. However this is the case in many hospitals. Neither CRP, leukocytes count nor infiltrate on CR were helpful in determining the cause of the respiratory tract infection. This is in accordance with the fact that there was no correlation between clinical diagnosis made by the physician and the laboratory diagnosis of influenza. To be able to start this study directly at the beginning of the influenza epidemic, only a limited number parameters were studied due to logistic reasons. However, we think this reflects the actual practice during outbreaks in hospitals. As was emphasized in the latest Dutch guidelines concerning ‘Community Acquired Pneumonia’ (CAP) [12], PSI is a useful tool for measuring the severity of the illness as well as predicting mortality. Results from this study show that PSI and the length of the hospital stay and mortality are significantly correlated. In this study population there was a significant correlation between PSI and outcome overall. However, PSI was not helpful in discriminating the cause of the infection. Finally, the results of this study reveal the complexity of the management of patient care and infection control at ER's in case of influenza pandemic. Without implementation of tight guidelines epidemic situations may be hard to control. ER's will become overcrowded with sick people and physicians cannot predict which patient has influenza or not. We postulate that the decision to take protective measure like isolation and treatment with antiviral drugs should not rely on the clinical diagnosis. In case of influenza pandemic measures should be universally implemented to protect both patients and healthcare workers in hospitals. When diagnosis of influenza is confirmed patients should be treated with antiviral therapy and isolation measures should be taken. Antibacterial therapy can be avoided when there is no alternative diagnosis and all cultures and serology are negative. Also, depending on the severity of the illness using the PSI. In case of severly ill patients, PSI 3 or higher, treatment with both antiviral as well as antibacterial therapy should be considered.

Contributors

AMvdH conceived the study, collected data, performed the analysis and wrote the manuscript. MS conceived the study, collected data and revised the manuscript. PCW extensively revised the manuscript. RF conceived the study. MH revised the manuscript and was responsible for all molecular data. PMS conceived the study and extensively revised the manuscript. AMvdH and PMS are guarantors.

Ethical approval

The study was evaluated and approved by the medical ethical committee (METOPP) since only standard procedures were conducted in this study.
  15 in total

1.  [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].

Authors:  J C de Jong; G F Rimmelzwaan; A I M Bartelds; A Meijer; R A M Fouchier; A D M E Osterhaus
Journal:  Ned Tijdschr Geneeskd       Date:  2005-10-15

Review 2.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

Review 3.  [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].

Authors:  J A Schouten; J M Prins; M Bonten; J E Degener; R Janknegt; J M R Hollander; R Jonkers; W Wijnands; T Verheij; A Sachs; B J Kullberg
Journal:  Ned Tijdschr Geneeskd       Date:  2005-11-05

Review 4.  Does this patient have influenza?

Authors:  Stephanie A Call; Mark A Vollenweider; Carlton A Hornung; David L Simel; W Paul McKinney
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

5.  Simultaneous detection of influenza viruses A and B using real-time quantitative PCR.

Authors:  L J van Elden; M Nijhuis; P Schipper; R Schuurman; A M van Loon
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.

Authors:  M Zambon; J Hays; A Webster; R Newman; O Keene
Journal:  Arch Intern Med       Date:  2001-09-24

7.  Accuracy of clinical diagnosis of influenza in outpatient children.

Authors:  Ville Peltola; Tanja Reunanen; Thedi Ziegler; Heli Silvennoinen; Terho Heikkinen
Journal:  Clin Infect Dis       Date:  2005-08-29       Impact factor: 9.079

8.  Predicting influenza infections during epidemics with use of a clinical case definition.

Authors:  G Boivin; I Hardy; G Tellier; J Maziade
Journal:  Clin Infect Dis       Date:  2000-11-06       Impact factor: 9.079

9.  Clinical signs and symptoms predicting influenza infection.

Authors:  A S Monto; S Gravenstein; M Elliott; M Colopy; J Schweinle
Journal:  Arch Intern Med       Date:  2000-11-27

10.  Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients.

Authors:  Hilary M Babcock; Liana R Merz; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2006-02-22       Impact factor: 3.254

View more
  10 in total

Review 1.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

2.  Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.

Authors:  E Terletskaia-Ladwig; M Eggers; S Meier; M Leinmüller; F Schneider; M Schmid; M Enders
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

3.  Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011.

Authors:  Timothy R Peters; Cynthia K Suerken; Beverly M Snively; James E Winslow; Milan D Nadkarni; Scott B Kribbs; Katherine A Poehling
Journal:  Acad Emerg Med       Date:  2013-08       Impact factor: 3.451

4.  Trends in Influenza Vaccine Uptake and Severe Influenza-Related Outcomes at Kaiser Permanente Southern California, 2007-2017.

Authors:  In-Lu Amy Liu; Hilary C Tanenbaum; Lei Qian; Lina S Sy; Wansu Chen; Steven J Jacobsen
Journal:  Perm J       Date:  2021-05

5.  Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis.

Authors:  Tabitha Woolpert; Stephanie Brodine; Hector Lemus; Jill Waalen; Patrick Blair; Dennis Faix
Journal:  BMC Infect Dis       Date:  2012-06-07       Impact factor: 3.090

6.  A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong.

Authors:  Joyce H S You; Eva S K Chan; Maggie Y K Leung; Margaret Ip; Nelson L S Lee
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

7.  Assessing Healthcare Utilization for Influenza-like Illness at an Emergency Department and a Student Health Service during the 2009-2010 H1N1 Pandemic.

Authors:  Ruchi Bhandari; Tara A Hartley; William G Lindsley; Melanie A Fisher; Jan E Palmer
Journal:  Infect Dis (Auckl)       Date:  2013-03-07

8.  Cost-Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms.

Authors:  Roland Diel; Albert Nienhaus
Journal:  Int J Environ Res Public Health       Date:  2019-07-03       Impact factor: 3.390

9.  Procalcitonin in children with suspected novel influenza A (H1N1) infection.

Authors:  Maarten Limper; Patrick M Smit; Karlien M Bongers; Anton P van Zanten; Paul H M Smits; Dees P M Brandjes; Jan Willem Mulder; Ines A von Rosenstiel; Eric C M van Gorp
Journal:  J Infect       Date:  2010-07-16       Impact factor: 6.072

Review 10.  [Seasonal flu].

Authors:  A Vabret; J Dina; D Cuvillon-Nimal; E Nguyen; S Gouarin; J Petitjean; J Brouard; F Freymuth
Journal:  Pathol Biol (Paris)       Date:  2010-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.